Page 96 - Programme book for The International Liver Congress 2015, EASL ILC 2015

SATURDAY, APRIL 25, 2015

Industry Satellite Symposia

7:30 - 8:30 Please refer to the Industry Section

General Session 3 & Award Ceremony 2 Hall D

SCIENTIFIC PROGRAMME Chairs:
Mauro Bernardi, Italy
A.Kadir Dokmeci, Turkey

ABSTRACT OMBITASVIR/PARITAPREVIR/RITONAVIR FOR
G13 TREATMENT OF HCV GENOTYPE 1B IN JAPANESE
08:30 - 08:45 PATIENTS WITH OR WITHOUT CIRRHOSIS: RESULTS
FROM GIFT-I
ABSTRACT Ken Sato, Japan
G14
08:45 - 09:00 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME
(SIRS) IS A MAJOR DETERMINANT OF TREATMENT
ABSTRACT RESPONSE TO TERLIPRESSIN FOR HEPATORENAL
G18 SYNDROME TYPE 1 (HRS-1)
09:00 - 09:15 Florence Wong, Canada

09:15 - 09:45 THE FXR AGONIST PX20606 REDUCES LIVER DAMAGE,
ABSTRACT FIBROSIS AND PORTAL HYPERTENSION IN CIRRHOTIC
G16 RATS
09:45 - 10:00 Philipp Schwabl, Austria

ABSTRACT Award Ceremony II
G17
10:00 - 10:15 THE COUNFOUNDING ROLE OF SEVERE
COMORBIDITIES AND ALCOHOL USE DISORDERS
ON PROGNOSIS IN CHRONIC HEPATITIS C VIRUS
INFECTION: AN ANALYSIS OF THE 2008-2012 FRENCH
NATIONAL HOSPITAL DISCHARGE DATABASE
Michaël Schwarzinger, France

A DISTINCT PROFILE OF LYSO-
PHOSPHATIDYLCHOLINES AND AMINO ACIDS
CHARACTERIZES NAFLD IN LEAN SUBJECTS
Alexandra Feldman, Austria

96 The International Liver Congress™ 2015 • ILC Programme